This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Type of economic evaluation
Cost-utility analysis
Study objective
The aim was to evaluate the cost-effectiveness of combined stroke unit care (SU) with early supported discharge (ESD) for patients with acute stroke, compared with SU without ESD, and compared with treatment in a general medical ward (GMW) without ESD.
Interventions
SU with ESD was compared with SU only and compared with treatment in a GMW only. The ESD programme allowed less disabled patients to be discharged early to undergo further rehabilitation at home.
Location/setting
UK/hospital.
Methods

Analytical approach:
A Markov model was constructed to simulate the management of the disease for the three strategies. The time horizon of the analysis was 10 years and the authors stated that a societal perspective was adopted.
Effectiveness data:
The clinical data were derived from the South London Stroke Register (SLSR) and a randomised controlled trial (RCT) of an ESD programme for patients with stroke. The data from SLSR were collected from November 2001 to January 2006. Of the patients enrolled in the ESD trial, 167 were in the ESD group and 164 were in the SU group. The primary outcome was a combination of death and activities of daily living scores as measured by the Barthel Index (BI).
Monetary benefit and utility valuations:
Health-related quality of life values were derived from the BI index using the conversion method developed by van Exel, et al. 2004 (see 'Other Publications of Related Interest' below for bibliographic details).
Measure of benefit:
The summary benefit measure was quality-adjusted life-years (QALYs). These were discounted at an annual rate of 3.5%.
Cost data:
Health care costs and productivity costs were considered. The health care costs included those of the hospital, nursing home, residential home and sheltered home stay. The costs of out-patient drugs and lab test (computed tomography and magnetic resonance imaging) were also considered. The productivity costs were estimated based on income loss due to
